ANNOVERA

Peak

segesterone acetate and ethinyl estradiol

NDAVAGINALRING

Approved

Aug 2018

Lifecycle

Peak

Competitive Pressure

0/100

Mechanism of Action

Estrogen Receptor Agonists

Pharmacologic Class:

Estrogen

Indications (1)

Loss of Exclusivity

LOE Date

Jun 21, 2039

161 months away

Patent Expiry

Jun 21, 2039

Patent Records (5)

Patent #	Expiry	Type	Use Code
10632066	Feb 1, 2039		U-2786
10765628	Feb 1, 2039		U-2787
10780047	Feb 1, 2039		U-2786
10918649	Jun 21, 2039	Product	—
10925882	Jun 21, 2039	Product	—

External Resources

Full prescribing information

FDA approval history

Drug nomenclature & identifiers